Epidemiology Practice Questions

Q: Which one of the following modes of intervention covers the process of advising a patient to change their lifestyle in order to prevent any risk factor for a disease?

Health promotion. ***Health promotion*** - This mode of intervention focuses on **lifestyle changes** and **behavioral modifications** through counseling and education to improve overall health and **prevent disease risk factors**. - It involves **advising patients** on healthy behaviors such as diet, exercise, stress management, and avoiding tobacco/alcohol. - Empowers individuals and communities to take control of their health through education and support. - This is a **primary prevention** strategy that occurs before any disease develops. *Specific protection* - This refers to measures aimed at preventing specific diseases through targeted interventions, such as **immunizations**, use of **personal protective equipment**, or specific prophylaxis. - While also primary prevention, it involves specific biological or environmental measures rather than general lifestyle counseling. - Does not encompass broad lifestyle advice for overall risk factor reduction. *Disability limitation* - This is a **secondary prevention** strategy that focuses on early diagnosis and prompt treatment to arrest disease progression. - Aims to minimize the impact of existing disease and prevent further **impairment** or **disability**. - Occurs after disease onset, not as a means of preventing risk factors through lifestyle advice. *Rehabilitation* - This is a **tertiary prevention** strategy involving restoration of function and well-being after illness, injury, or disability. - Includes physical therapy, occupational therapy, and adaptive measures to improve quality of life. - Occurs well after a health event, not in the disease-free state where lifestyle counseling for prevention takes place.

Q: In the context of measles, which type of epidemic is characterized by all cases clustering within one incubation period?

Point source epidemic. ***Point source epidemic*** - This type of epidemic occurs when all cases are exposed to the same **common source** over a **brief period**, typically within one incubation period. - The rapid clustering of measles cases suggests a single exposure event to the virus, leading to simultaneous onset of symptoms. - The epidemic curve shows a sharp rise and fall within one incubation period. *Continuous source epidemic* - This involves ongoing exposure to the **common source** over an extended period, resulting in a prolonged epidemic curve with cases presenting over multiple incubation periods. - The epidemic curve shows a plateau pattern as exposure continues. *Propagated epidemic* - Also called **person-to-person epidemic**, this occurs when infection spreads through direct transmission from one person to another. - Cases appear over **several incubation periods** as the disease propagates through the population in successive generations. - The epidemic curve shows multiple peaks corresponding to successive waves of transmission. *Endemic* - An endemic disease is constantly present in a population at a **baseline level**, with a predictable number of cases over time, rather than a sudden clustering. - Measles, if endemic, would show a consistent pattern of cases, not a sudden outbreak over one incubation period.

Q: HIV sentinel surveillance is used for:

Monitoring trends in HIV infection. ***Monitoring trends in HIV infection*** - **HIV sentinel surveillance** is specifically designed to track **HIV prevalence trends** over time in selected sentinel populations (ANC attendees, STD clinic attendees, high-risk groups). - The primary objective is to monitor **how HIV infection rates change** over time, helping identify emerging epidemics, evaluate intervention programs, and guide public health policy. - As per **NACO and WHO guidelines**, sentinel surveillance provides repeated cross-sectional prevalence measurements at fixed sites to detect temporal trends in HIV infection. *Monitoring disease trends* - This is **too broad and vague** for the specific purpose of HIV sentinel surveillance. - "Disease trends" could refer to AIDS progression, opportunistic infections, or other disease manifestations, which are **not the focus** of sentinel surveillance. - Sentinel surveillance specifically tracks **infection (seroprevalence)**, not general disease patterns. *Prevalence of HIV infection* - While sentinel surveillance **does measure prevalence**, this is a **method rather than the ultimate purpose**. - Prevalence measurements are taken repeatedly at different time points specifically to **monitor trends**, making this incomplete as the primary objective. *Detection of high-risk group* - Identification of high-risk groups is typically done through **epidemiological studies** and behavioral surveys, not sentinel surveillance. - Sentinel surveillance may **include** high-risk populations as sentinel sites, but its purpose is to monitor trends **within** these groups, not to detect them.

Q: Which is the best index for assessing the burden of disease?

Disability Adjusted Life Years (DALY). ***Disability Adjusted Life Years (DALY)*** - **DALY** is a comprehensive measure that quantifies the total burden of disease by combining years of life lost due to premature mortality (YLL) and years lived with disability (YLD). - It considers both the **quantity** and **quality of life**, making it an excellent index for assessing the overall impact of diseases on a population. *Case fatality rate (CFR)* - **CFR** measures the proportion of people who die from a specified disease among all individuals diagnosed with the disease within a given period. - While it indicates the **severity** of a disease, it does not account for non-fatal disabling outcomes or years of life lost. *Morbidity rate* - The **morbidity rate** refers to the incidence or prevalence of a disease in a population. - It measures the **frequency** of illness but does not quantify the impact of either premature death or disability. *Dependency ratio* - The **dependency ratio** is an indicator of the age structure of a population, comparing the number of dependants (young and old) to the working-age population. - It relates to the **economic burden** on a society due to age demographics, not directly to the health burden of diseases.

Q: To determine the endemicity of hepatitis B, what should be measured?

HBsAg (Hepatitis B surface antigen). ***HBsAg*** - **HBsAg (Hepatitis B surface antigen)** is the primary marker used to determine the **endemicity** of hepatitis B because its persistent presence indicates **chronic infection**. - A high prevalence of HBsAg in a population signifies a high burden of chronic hepatitis B infection, reflecting the endemic nature of the disease in that region. *HBcAg (Hepatitis B core antigen)* - **HBcAg** is an **intracellular antigen** and is not detectable in the serum, making it unsuitable for population-level screening or endemicity assessment. - While important for viral replication, its absence in routine blood tests means it cannot be used to gauge the prevalence of infection in a community. *HBeAg (Hepatitis B e antigen)* - **HBeAg** indicates **active viral replication** and high infectivity but is not the best marker for overall endemicity. - A positive HBeAg suggests active disease and high transmissibility in an infected individual, but not the general prevalence of chronic infection in a population. *Anti-HBeAg (Hepatitis B e antibody)* - **Anti-HBeAg** indicates a **decrease in viral replication** and a lower risk of transmission, often representing a stage of immune control. - While useful for monitoring disease progression, it is an antibody response and does not directly measure the presence of chronic infection or endemicity.

Q: For international comparisons, the perinatal mortality rate is calculated as late fetal deaths (28 weeks' gestation or more) plus early neonatal deaths (in the first week) in a year per:

1,000 live births. ***1,000 live births*** - Perinatal mortality rate is typically expressed per **1,000 live births** for international comparisons to standardize reporting and analysis of fetal and early neonatal deaths. - This denominator provides a good balance for statistical significance without making the numbers too small or too large, allowing for meaningful comparisons between populations. *100 live births* - Using **100 live births** as the denominator would result in a perinatal mortality rate that appears numerically higher, which could complicate comparisons with other standard health indicators usually reported per 1,000 or 100,000. - While it's a valid way to express a rate, it's not the **standard convention** for perinatal mortality in international settings. *10,000 live births* - Expressing the rate per **10,000 live births** would lead to very small numbers, potentially making subtle differences harder to appreciate and interpret. - It's not the **standard denominator** used for perinatal mortality, although it might be used for rarer events. *100,000 live births* - A denominator of **100,000 live births** is typically reserved for very rare events or conditions where the incidence is extremely low, such as maternal mortality, to obtain more manageable integer values. - Perinatal mortality is more common than events reported per 100,000, so this denominator would yield **fractions or very small whole numbers**, making it less intuitive for this specific measure.

Q: The time interval between diagnosis by early detection and diagnosis by other means is what?

Lead time. ***Lead time*** - **Lead time** refers to the interval between diagnosis by screening or early detection and the time at which the diagnosis would have been made by usual clinical presentation or other means. - A longer lead time in screening programs can make it seem like screened individuals live longer, even if the treatment efficacy is the same (known as **lead time bias**). *Incubation period* - The **incubation period** is the time from exposure to an infectious agent to the onset of symptoms for an infectious disease. - It is not related to the comparison of diagnosis times using different methods. *Serial interval* - The **serial interval** in epidemiology is the time between symptom onset in an infected person and symptom onset in a secondary case infected by the first person. - This concept is specific to the transmission dynamics of infectious diseases and not to diagnostic timing. *Latent period* - The **latent period** can refer to various concepts depending on the context; in infectious diseases, it's the time from infection to infectivity, or in chronic diseases, it can be the time from exposure to a causal agent to the development of detectable disease. - While it relates to disease progression, it specifically measures the time until detectability or infectivity, not the difference in diagnostic timings between early detection and other methods.

Q: Which of the following is considered the most reliable indicator of mortality in a population?

ASDR. ***ASDR (Age-Specific Death Rate)*** * **ASDR** is considered the most reliable indicator of mortality because it takes into account the different **age structures** of populations being compared. * It provides a more accurate picture of mortality by showing the number of deaths relative to the population in specific age groups, which is crucial for **epidemiological studies** and public health planning. *CDR (Crude Death Rate)* * The **CDR** is the total number of deaths in a given period divided by the total population, which can be misleading when comparing populations with different **age distributions**. * A high CDR in one population might be due to a larger proportion of elderly individuals, rather than higher actual mortality risk across all age groups. *PMR (Proportional Mortality Ratio)* * The **PMR** expresses the proportion of deaths due to a specific cause out of all deaths, rather than the risk of dying from that cause in the entire population. * It does not reflect the **absolute risk** of death and can be influenced by changes in other causes of death. *CFR (Case Fatality Rate)* * The **CFR** measures the proportion of people diagnosed with a specific disease who die from that disease within a certain period. * While useful for understanding the severity of a disease, it is not an indicator of overall mortality in a population but rather the **lethality** of a particular condition among those affected.

Q: What is the prevalence in a given population of 1000, where there are 50 new cases of lung cancer and 100 old cases of lung cancer in the same population?

15%. ***Correct: 15%*** - **Prevalence** is the proportion of a population living with a disease at a specific time point. It includes both new and existing (old) cases. - **Calculation:** Total cases = 50 (new cases) + 100 (old cases) = 150 cases - **Prevalence rate** = (150 / 1000) × 100% = **15%** - Prevalence answers the question: "What proportion of the population has the disease right now?" *Incorrect: 1.50%* - This value represents a calculation error, likely from dividing 150 by 10,000 instead of 1,000 - It underestimates the actual prevalence by a factor of 10 - Would only be correct if there were 15 total cases, not 150 *Incorrect: 150* - This is the **absolute count** of individuals with lung cancer (both new and old cases) - Prevalence must be expressed as a **proportion or percentage**, not a raw count - Raw counts cannot be compared across populations of different sizes *Incorrect: 13%* - This would only be correct if there were 130 total cases, not 150 - This miscalculation fails to properly sum the new cases (50) and old cases (100) - The arithmetic is incorrect: 50 + 100 ≠ 130

Q: A disease has three times more incidence in females as compared to males, with the same prevalence in both males and females. The TRUE statement is:

Increase fatality in women. ***Increase fatality in women*** - **Prevalence = Incidence × Duration of disease** - Given: Incidence in females = 3 × Incidence in males, but Prevalence is same in both - For males: Prevalence = I_m × D_m - For females: Prevalence = 3I_m × D_f - Since prevalences are equal: I_m × D_m = 3I_m × D_f - Therefore: **D_f = D_m/3** (females have 1/3 the disease duration of males) - **Shorter disease duration means worse survival and increased fatality in women** *More survival in women* - This would be incorrect because if women had better survival, their disease duration would be longer - With 3× higher incidence AND longer duration, the prevalence in women would be much higher than men, not equal - The equal prevalence despite higher incidence indicates women are dying faster (shorter duration) *Better prognosis in men* - While men do have longer disease duration (3× that of women), this option is vague - "Prognosis" could refer to recovery or survival, but the question specifically asks about the relationship between incidence and prevalence - The more precise statement is about increased fatality in women, which directly explains the epidemiological relationship *Less fatality in men* - This is essentially the same as saying "more survival in men" or "better prognosis in men" - While men do have less fatality (longer duration), the question stem focuses on the paradox of higher incidence in women with equal prevalence - The **key insight** is recognizing increased fatality in women, which is the direct answer to why higher incidence doesn't lead to higher prevalence

Question 1

Which one of the following modes of intervention covers the process of advising a patient to change their lifestyle in order to prevent any risk factor for a disease?

Accepted Answer

Health promotion

Answer

Specific protection

Answer

Disability limitation

Answer

Rehabilitation

Question 2

In the context of measles, which type of epidemic is characterized by all cases clustering within one incubation period?

Accepted Answer

Point source epidemic

Answer

Continuous source epidemic

Answer

Propagated epidemic

Answer

Endemic

Question 3

HIV sentinel surveillance is used for:

Accepted Answer

Monitoring trends in HIV infection

Answer

Detection of high-risk group

Answer

Prevalence of HIV infection

Answer

Monitoring disease trends

Question 4

Which is the best index for assessing the burden of disease?

Accepted Answer

Disability Adjusted Life Years (DALY)

Answer

Case fatality rate (CFR)

Answer

Morbidity rate

Answer

Dependency ratio

Question 5

To determine the endemicity of hepatitis B, what should be measured?

Accepted Answer

HBsAg (Hepatitis B surface antigen)

Answer

HBcAg (Hepatitis B core antigen)

Answer

HBeAg (Hepatitis B e antigen)

Answer

Anti-HBeAg (Hepatitis B e antibody)

Question 6

For international comparisons, the perinatal mortality rate is calculated as late fetal deaths (28 weeks' gestation or more) plus early neonatal deaths (in the first week) in a year per:

Accepted Answer

1,000 live births

Answer

100 live births

Answer

10,000 live births

Answer

100,000 live births

Question 7

The time interval between diagnosis by early detection and diagnosis by other means is what?

Accepted Answer

Lead time

Answer

Incubation period

Answer

Serial interval

Answer

Latent period

Question 8

Which of the following is considered the most reliable indicator of mortality in a population?

Accepted Answer

ASDR

Answer

CDR

Answer

PMR

Answer

CFR

Question 9

What is the prevalence in a given population of 1000, where there are 50 new cases of lung cancer and 100 old cases of lung cancer in the same population?

Accepted Answer

15%

Answer

1.50%

Answer

150

Answer

13%

Question 10

A disease has three times more incidence in females as compared to males, with the same prevalence in both males and females. The TRUE statement is:

Accepted Answer

Increase fatality in women

Answer

More survival in women

Answer

Less fatality in men

Answer

Better prognosis in men

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?